Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04418011 · ClinicalTrials.gov registry record · NA
Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders
A NA study, sponsored by Centre for Addiction and Mental Health.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT04418011 is a NA study that has completed, run by Centre for Addiction and Mental Health. The registered enrollment target is 70 participants.
The verdict
NCT04418011, a NA study, has completed, sponsored by Centre for Addiction and Mental Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
In this study, the investigators will be examining the effects of repetitive transcranial magnetic stimulation (rTMS) and intermittent theta burst stimulation (iTBS) on social cognitive impairments in individuals with schizophrenia spectrum disorders. Participants will be chosen by chance to receive either active rTMS stimulation, active iTBS stimulation, sham rTMS, or sham iTBS. The investigators predict that active 10Hz and iTBS stimulation will improve social cognitive impairments compared to sham stimulation. We aim to identify which type of active stimulation is most effective at inducing changes social cognition brain circuitry and secondarily which type of active stimulation is best tolerated and most effective at inducing changes in social cognitive performance.
Interventions
- DEVICE Repetitive Transcranial Magnetic Stimulation
- DEVICE Repetitive Transcranial Magnetic Stimulation (Intermittent Theta Burst Stimulation)
- DEVICE Repetitive Transcranial Magnetic Stimulation (Sham)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2020-11-30 |
| Est. Completion | 2023-02-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04418011
The ClinicalTrials.gov registry entry for NCT04418011 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centre for Addiction and Mental Health, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Repetitive Transcranial Magnetic Stimulation is the first listed.
NCT04418011 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04418011 about?
NCT04418011 is a clinical study titled "Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders". In this study, the investigators will be examining the effects of repetitive transcranial magnetic stimulation (rTMS) and intermittent theta burst stimulation (iTBS) on social cognitive impairments in individuals with schizophrenia spectrum disorders. Participants will be chosen by chance to receive...
What is the current status of trial NCT04418011?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2020-11-30. Estimated completion is 2023-02-02.
What interventions are being tested in trial NCT04418011?
The interventions under investigation include: Repetitive Transcranial Magnetic Stimulation (DEVICE), Repetitive Transcranial Magnetic Stimulation (Intermittent Theta Burst Stimulation) (DEVICE), Repetitive Transcranial Magnetic Stimulation (Sham) (DEVICE).
Who is sponsoring clinical trial NCT04418011?
This trial is sponsored by Centre for Addiction and Mental Health, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.